These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 12871494)
21. Fibrin γ/γ' influences the secretion of fibrinolytic components and clot structure. Cantero M; Rojas H; Anglés-Cano E; Marchi R BMC Mol Cell Biol; 2019 Nov; 20(1):47. PubMed ID: 31675913 [TBL] [Abstract][Full Text] [Related]
22. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly. Mosesson MW Blood Coagul Fibrinolysis; 1997 Jul; 8(5):257-67. PubMed ID: 9282789 [TBL] [Abstract][Full Text] [Related]
23. Fibrinogen and fibrin. Weisel JW Adv Protein Chem; 2005; 70():247-99. PubMed ID: 15837518 [TBL] [Abstract][Full Text] [Related]
24. Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains. Siebenlist KR; Mosesson MW; Hernandez I; Bush LA; Di Cera E; Shainoff JR; Di Orio JP; Stojanovic L Blood; 2005 Oct; 106(8):2730-6. PubMed ID: 16002430 [TBL] [Abstract][Full Text] [Related]
25. Position of gamma-chain carboxy-terminal regions in fibrinogen/fibrin cross-linking mixtures. Siebenlist KR; Meh DA; Mosesson MW Biochemistry; 2000 Nov; 39(46):14171-5. PubMed ID: 11087365 [TBL] [Abstract][Full Text] [Related]
26. Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis. Meh DA; Mosesson MW; DiOrio JP; Siebenlist KR; Hernandez I; Amrani DL; Stojanovich L Blood Coagul Fibrinolysis; 2001 Dec; 12(8):627-37. PubMed ID: 11734662 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of the factors contributing to fibrin-dependent plasminogen activation. Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195 [TBL] [Abstract][Full Text] [Related]
36. Fibrin clot structure and mechanics associated with specific oxidation of methionine residues in fibrinogen. Weigandt KM; White N; Chung D; Ellingson E; Wang Y; Fu X; Pozzo DC Biophys J; 2012 Dec; 103(11):2399-407. PubMed ID: 23283239 [TBL] [Abstract][Full Text] [Related]
37. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents. Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085 [TBL] [Abstract][Full Text] [Related]
38. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site. Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375 [TBL] [Abstract][Full Text] [Related]
39. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin. de Haan J; van Oeveren W Thromb Res; 1998 Nov; 92(4):171-9. PubMed ID: 9840026 [TBL] [Abstract][Full Text] [Related]